CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Other events
- 8-K Event Executive or director change
- 4 Returned to the company Director returned 187,804 shares (to the company)
- 4 Returned to the company Director returned 40,000 shares (to the company)
- 4 Returned to the company Chief Executive Officer returned 80,000 shares (to the company)
- 4 Returned to the company Director returned 40,000 shares (to the company)
- 4 Open-market buy Chief Executive Officer bought 112,371 shares at $0.22 ($25,047)
- 4 Open-market buy Chief Commercial Officer bought 100,000 shares at $0.24 ($24,480)
- 8-K Event Auditor change
- 8-K Event Regulation FD disclosure
- 4/A Open-market buy Chief Financial Officer bought 90,000 shares at $0.23 ($20,700)
- 4/A Open-market buy Chief Executive Officer bought 222,000 shares at $0.24 ($52,614)
- 8-K Event Delisting notice
- 4 Grant or award Chief Executive Officer acquired 222,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 90,000 shares (grant or award)
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 10 of 46 · 907 filings